Artal Group S.A.

Holdings History for Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

Symbol: SPRO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2022		-0.05%	$0	0	-500,000	-100%	$2.37	Q4 2022
30 Sep 2022	0.05%	0%	$1,000,000	500,000	0		$2.00	Q3 2022
30 Jun 2022	0.02%	0%	$371,000	500,000	0		$0.74	Q2 2022
31 Mar 2022	0.18%	0%	$4,350,000	500,000	0		$8.70	Q1 2022
31 Dec 2021	0.24%	0%	$8,005,000	500,000	0		$16.01	Q4 2021
30 Sep 2021	0.23%	0%	$9,205,000	500,000	0		$18.41	Q3 2021
30 Jun 2021	0.16%	0%	$6,980,000	500,000	0		$13.96	Q2 2021
31 Mar 2021	0.16%	0%	$7,360,000	500,000	0		$14.72	Q1 2021
31 Dec 2020	0.22%	-0.04%	$9,695,000	500,000	-100,000	-17%	$19.39	Q4 2020
30 Sep 2020	0.22%	+0.02%	$6,696,000	600,000	+54,960	+10%	$11.16	Q3 2020
30 Jun 2020	0.25%	-0.01%	$7,374,000	545,040	-30,960	-5.4%	$13.53	Q2 2020
31 Mar 2020	0.22%	+0.03%	$4,654,000	576,000	+76,000	+15%	$8.08	Q1 2020
31 Dec 2019	0.2%	-0.02%	$4,808,000	500,000	-40,000	-7.4%	$9.62	Q4 2019
30 Sep 2019	0.28%	0%	$5,724,000	540,000	0		$10.60	Q3 2019
30 Jun 2019	0.29%	-0.03%	$6,215,000	540,000	-60,000	-10%	$11.51	Q2 2019
31 Mar 2019	0.37%	0%	$7,686,000	600,000	0		$12.81	Q1 2019
31 Dec 2018	0.18%	0%	$3,690,000	600,000	0		$6.15	Q4 2018
30 Sep 2018	0.22%	+0.09%	$6,306,000	600,000	+250,000	+71%	$10.51	Q3 2018
30 Jun 2018	0.13%	0%	$5,135,000	350,000	0		$14.67	Q2 2018
31 Mar 2018	0.07%	0%	$4,988,000	350,000	0		$14.25	Q1 2018
31 Dec 2017	0.08%	+0.08%	$4,113,000	350,000	+350,000	NEW	$11.75	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.